262 related articles for article (PubMed ID: 22072024)
1. Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.
Aringer M; Burkhardt H; Burmester GR; Fischer-Betz R; Fleck M; Graninger W; Hiepe F; Jacobi AM; Kötter I; Lakomek HJ; Lorenz HM; Manger B; Schett G; Schmidt RE; Schneider M; Schulze-Koops H; Smolen JS; Specker C; Stoll T; Strangfeld A; Tony HP; Villiger PM; Voll R; Witte T; Dörner T
Lupus; 2012 Apr; 21(4):386-401. PubMed ID: 22072024
[TBL] [Abstract][Full Text] [Related]
2. Biologics in SLE: the current status.
Rajadhyaksha AG; Mehra S; Nadkar MY
J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
[TBL] [Abstract][Full Text] [Related]
3. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Fanouriakis A; Kostopoulou M; Alunno A; Aringer M; Bajema I; Boletis JN; Cervera R; Doria A; Gordon C; Govoni M; Houssiau F; Jayne D; Kouloumas M; Kuhn A; Larsen JL; Lerstrøm K; Moroni G; Mosca M; Schneider M; Smolen JS; Svenungsson E; Tesar V; Tincani A; Troldborg A; van Vollenhoven R; Wenzel J; Bertsias G; Boumpas DT
Ann Rheum Dis; 2019 Jun; 78(6):736-745. PubMed ID: 30926722
[TBL] [Abstract][Full Text] [Related]
4. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance.
Marinho A; Delgado Alves J; Fortuna J; Faria R; Almeida I; Alves G; Araújo Correia J; Campar A; Brandão M; Crespo J; Marado D; Matos-Costa J; Oliveira S; Salvador F; Santos L; Silva F; Fernandes M; Vasconcelos C
Front Immunol; 2023; 14():1117699. PubMed ID: 37138867
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
7. Treatment of systemic lupus erythematosus - 2013 update.
Belmont HM
Bull Hosp Jt Dis (2013); 2013; 71(3):208-13. PubMed ID: 24151947
[TBL] [Abstract][Full Text] [Related]
8. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
Staveri C; Karokis D; Liossis SC
Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
[TBL] [Abstract][Full Text] [Related]
9. [Management of systemic lupus erythematosus].
Aringer M; Schneider M
Internist (Berl); 2016 Nov; 57(11):1052-1059. PubMed ID: 27670650
[TBL] [Abstract][Full Text] [Related]
10. Pragmatic approaches to therapy for systemic lupus erythematosus.
Xiong W; Lahita RG
Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
[TBL] [Abstract][Full Text] [Related]
11. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.
Kleinmann JF; Tubach F; Le Guern V; Mathian A; Richez C; Saadoun D; Sacre K; Sellam J; Seror R; Amoura Z; Andres E; Audia S; Bader-Meunier B; Blaison G; Bonnotte B; Cacoub P; Caillard S; Chiche L; Chosidow O; Costedoat-Chalumeau N; Daien C; Daugas E; Derdèche N; Doria A; Fain O; Fakhouri F; Farge D; Gabay C; Guillo S; Hachulla E; Hajjaj-Hassouni N; Hamidou M; Houssiau FA; Jourde-Chiche N; Koné-Paut I; Ladjouz-Rezig A; Lambotte O; Lipsker D; Mariette X; Martin-Silva N; Martin T; Maurier F; Meckenstock R; Mékinian A; Meyer O; Mohamed S; Morel J; Moulin B; Mulleman D; Papo T; Poindron V; Puéchal X; Punzi L; Quartier P; Sailler L; Smail A; Soubrier M; Sparsa A; Tazi-Mezalek Z; Zakraoui L; Zuily S; Sibilia J; Gottenberg JE
Autoimmun Rev; 2017 Jun; 16(6):650-657. PubMed ID: 28434948
[TBL] [Abstract][Full Text] [Related]
12. The Diagnosis and Treatment of Systemic Lupus Erythematosus.
Kuhn A; Bonsmann G; Anders HJ; Herzer P; Tenbrock K; Schneider M
Dtsch Arztebl Int; 2015 Jun; 112(25):423-32. PubMed ID: 26179016
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
Constantin A; Năstase D; Tulbă D; Bălănescu P; Băicuș C
Lupus; 2020 Oct; 29(12):1509-1519. PubMed ID: 32757735
[TBL] [Abstract][Full Text] [Related]
14. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement.
Vitali C; Doria A; Tincani A; Fabbri P; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
Clin Exp Rheumatol; 1996; 14 Suppl 16():S17-22. PubMed ID: 9049449
[TBL] [Abstract][Full Text] [Related]
15. Use of biologics in SLE: a review of the evidence from a clinical perspective.
Aytan J; Bukhari MA
Rheumatology (Oxford); 2016 May; 55(5):775-9. PubMed ID: 26424838
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].
Ramos-Casals M; Ruiz-Irastorza G; Jiménez-Alonso J; Khamashta MA;
Rev Clin Esp (Barc); 2013; 213(1):42-58. PubMed ID: 23266125
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations.
Askanase AD; Furie RA; Dall'Era M; Bomback AS; Schwarting A; Zhao MH; Bruce IN; Khamashta M; Rubin B; Carroll A; Daniels M; Levy RA; van Vollenhoven R; Urowitz MB
Lupus Sci Med; 2024 May; 11(1):. PubMed ID: 38777595
[TBL] [Abstract][Full Text] [Related]
18. Biologic therapies in systemic lupus erythematosus.
Bernal CB; Zamora LD; Navarra SV
Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
[TBL] [Abstract][Full Text] [Related]
19. Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review.
Samotij D; Reich A
Biomed Res Int; 2019; 2019():8142368. PubMed ID: 31396534
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for juvenile-onset systemic lupus erythematosus.
Carreño L; López-Longo FJ; González CM; Monteagudo I
Paediatr Drugs; 2002; 4(4):241-56. PubMed ID: 11960513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
